Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
Will Jackson(University of Michigan), Jéssica Silva(University of Michigan), Holly Hartman(University of Michigan), Robert T. Dess(University of Michigan), Amar U. Kishan(University of California, Los Angeles), Whitney H. Beeler(University of Michigan), Laila A. Gharzai(University of Michigan), E Jaworski(University of Michigan), Rohit Mehra(University of Michigan), Jason W.D. Hearn(University of Michigan), Todd M. Morgan(University of Michigan), Simpa S. Salami(University of Michigan), Matthew R. Cooperberg(University of California, San Francisco), Brandon A. Mahal(Brigham and Women's Hospital), Payal Soni(University of Michigan), Samuel D. Kaffenberger(University of Michigan), Paul L. Nguyen(Brigham and Women's Hospital), Neil Desai(The University of Texas Southwestern Medical Center), Felix Y. Feng(University of California, San Francisco), Zachary S. Zumsteg(Cedars-Sinai Medical Center), Daniel E. Spratt(University of Michigan)
International Journal of Radiation Oncology*Biology*Physics
April 6, 2019
Cited by 345Open Access
Abstract
Related Papers
Projections of the Cost of Cancer Care in the United States: 2010-2020
Angela B. Mariotto, K. Robin Yabroff, Yu‐Hsuan Joni Shao et al.|JNCI Journal of the National Cancer Institute|2011|2.6k
Long-Term Outcomes From a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer
Christopher King, James D. Brooks, Harcharan Gill et al.|International Journal of Radiation Oncology*Biology*Physics|2011|406
Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results
Berit Madsen, R.A. Hsi, Huong Pham et al.|International Journal of Radiation Oncology*Biology*Physics|2007|378